vs
FENNEC PHARMACEUTICALS INC.（FENC）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
FENNEC PHARMACEUTICALS INC.的季度营收约是FIRST US BANCSHARES, INC.的1.3倍（$13.8M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -34.7%，领先55.2%），FENNEC PHARMACEUTICALS INC.同比增速更快（73.8% vs 7.1%），过去两年FIRST US BANCSHARES, INC.的营收复合增速更高（2.6% vs -26.3%）
Fennec制药是一家生物制药企业，专注于开发和商业化可降低儿童癌症患者治疗相关副作用的特种疗法，核心产品针对化疗引发的耳毒性，主要市场覆盖北美，服务肿瘤诊疗机构及儿童肿瘤患者群体。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
FENC vs FUSB — 直观对比
营收规模更大
FENC
是对方的1.3倍
$10.4M
营收增速更快
FENC
高出66.8%
7.1%
净利率更高
FUSB
高出55.2%
-34.7%
两年增速更快
FUSB
近两年复合增速
-26.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $10.4M |
| 净利润 | $-4.8M | $2.1M |
| 毛利率 | — | — |
| 营业利润率 | -18.5% | 28.1% |
| 净利率 | -34.7% | 20.4% |
| 营收同比 | 73.8% | 7.1% |
| 净利润同比 | -141.1% | 24.2% |
| 每股收益（稀释后） | $-0.17 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FENCFUSB
| Q4 25 | $13.8M | $10.4M | ||
| Q3 25 | $12.5M | $10.5M | ||
| Q2 25 | $9.7M | $10.3M | ||
| Q1 25 | $8.8M | $9.8M | ||
| Q4 24 | $7.9M | $9.7M | ||
| Q3 24 | $7.0M | $10.1M | ||
| Q2 24 | $7.3M | $10.0M | ||
| Q1 24 | $25.4M | $9.9M |
净利润FENCFUSB
| Q4 25 | $-4.8M | $2.1M | ||
| Q3 25 | $-638.0K | $1.9M | ||
| Q2 25 | $-3.2M | $155.0K | ||
| Q1 25 | $-1.2M | $1.8M | ||
| Q4 24 | $-2.0M | $1.7M | ||
| Q3 24 | $-5.7M | $2.2M | ||
| Q2 24 | $-5.6M | $2.1M | ||
| Q1 24 | $12.8M | $2.1M |
营业利润率FENCFUSB
| Q4 25 | -18.5% | 28.1% | ||
| Q3 25 | -1.5% | 23.9% | ||
| Q2 25 | -28.3% | 1.6% | ||
| Q1 25 | -9.2% | 23.8% | ||
| Q4 24 | -11.8% | 23.8% | ||
| Q3 24 | -74.6% | 29.2% | ||
| Q2 24 | -69.4% | 27.4% | ||
| Q1 24 | 54.2% | 27.8% |
净利率FENCFUSB
| Q4 25 | -34.7% | 20.4% | ||
| Q3 25 | -5.1% | 18.4% | ||
| Q2 25 | -32.7% | 1.5% | ||
| Q1 25 | -13.3% | 18.1% | ||
| Q4 24 | -25.0% | 17.6% | ||
| Q3 24 | -82.2% | 22.0% | ||
| Q2 24 | -76.5% | 21.2% | ||
| Q1 24 | 50.6% | 21.3% |
每股收益（稀释后）FENCFUSB
| Q4 25 | $-0.17 | $0.36 | ||
| Q3 25 | $-0.02 | $0.32 | ||
| Q2 25 | $-0.11 | $0.03 | ||
| Q1 25 | $-0.04 | $0.29 | ||
| Q4 24 | $-0.02 | $0.29 | ||
| Q3 24 | $-0.21 | $0.36 | ||
| Q2 24 | $-0.20 | $0.34 | ||
| Q1 24 | $0.41 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.8M | $73.5M |
| 总债务越低越好 | — | $10.9M |
| 股东权益账面价值 | $35.5M | $105.6M |
| 总资产 | $70.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资FENCFUSB
| Q4 25 | $36.8M | $73.5M | ||
| Q3 25 | $21.9M | $54.7M | ||
| Q2 25 | $18.7M | $54.0M | ||
| Q1 25 | $22.7M | $56.0M | ||
| Q4 24 | $26.6M | $47.2M | ||
| Q3 24 | $40.3M | $82.3M | ||
| Q2 24 | $43.1M | $58.2M | ||
| Q1 24 | $51.2M | $60.2M |
总债务FENCFUSB
| Q4 25 | — | $10.9M | ||
| Q3 25 | $19.4M | $10.9M | ||
| Q2 25 | $19.4M | $10.9M | ||
| Q1 25 | $19.4M | $10.9M | ||
| Q4 24 | $19.3M | $10.9M | ||
| Q3 24 | $32.1M | $10.9M | ||
| Q2 24 | $31.8M | $10.8M | ||
| Q1 24 | $31.3M | $10.8M |
股东权益FENCFUSB
| Q4 25 | $35.5M | $105.6M | ||
| Q3 25 | $-4.5M | $104.2M | ||
| Q2 25 | $-7.5M | $101.9M | ||
| Q1 25 | $-5.9M | $101.2M | ||
| Q4 24 | $-5.9M | $98.6M | ||
| Q3 24 | $-5.2M | $98.5M | ||
| Q2 24 | $-1.4M | $93.8M | ||
| Q1 24 | $3.0M | $92.3M |
总资产FENCFUSB
| Q4 25 | $70.6M | $1.2B | ||
| Q3 25 | $49.3M | $1.1B | ||
| Q2 25 | $44.9M | $1.1B | ||
| Q1 25 | $46.4M | $1.1B | ||
| Q4 24 | $44.9M | $1.1B | ||
| Q3 24 | $58.9M | $1.1B | ||
| Q2 24 | $63.2M | $1.1B | ||
| Q1 24 | $69.2M | $1.1B |
负债/权益比FENCFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | 10.40× | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.0M | $12.3M |
| 自由现金流经营现金流 - 资本支出 | — | $9.1M |
| 自由现金流率自由现金流/营收 | — | 87.2% |
| 资本支出强度资本支出/营收 | — | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | — | $16.0M |
8季度趋势，按日历期对齐
经营现金流FENCFUSB
| Q4 25 | $-6.0M | $12.3M | ||
| Q3 25 | $1.5M | $4.2M | ||
| Q2 25 | $-3.7M | $3.9M | ||
| Q1 25 | $-4.3M | $1.8M | ||
| Q4 24 | $-1.5M | $7.8M | ||
| Q3 24 | $-2.2M | $1.9M | ||
| Q2 24 | $-8.4M | $2.5M | ||
| Q1 24 | $39.0M | $825.0K |
自由现金流FENCFUSB
| Q4 25 | — | $9.1M | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $-142.0K |
自由现金流率FENCFUSB
| Q4 25 | — | 87.2% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | — | 58.2% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 23.5% | ||
| Q1 24 | — | -1.4% |
资本支出强度FENCFUSB
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 9.8% |
现金转化率FENCFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | — | 25.16× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | 3.04× | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
